Carboplatin in metastatic castration-resistant prostate cancer patients with molecular alterations of the DNA damage repair pathway: the PRO-CARBO phase II trial.

Elodie CoquanNicolas PenelJustine LequesneRaphaël LemanPernelle LavaudZoé NevierePierre-Emmanuel BrachetEmeline MeriauxAurélien CarnotJérémy BoutroisMarie CasteraNicolas GoardonEtienne MullerAlexandra LeconteAntoine Thiery-VuilleminBénédicte ClarisseFlorence Joly

Published in: Therapeutic advances in urology (2024)

NCT03652493, EudraCT ID number 2017-004764-35.

Keyphrases

dna damage
squamous cell carcinoma
small cell lung cancer
oxidative stress
dna repair
phase ii study
open label
anti inflammatory
phase iii
single molecule
clinical trial
placebo controlled
study protocol
rectal cancer